Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluentialReciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundHigh-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of Obesity
Hildebrandt, M. A., Hoffmann, C., Sherrill–Mix, S. A., Keilbaugh, S. A., Hamady, M., Chen, Y., Knight, R., Ahima, R. S., Bushman, F., & Wu, G. D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.042 · Cited by 1,576 · cited 2×
“Western diet with its high content of fat and refined sugars is a risk factor for the development of CD [109] probably inducing a low-grade inflammation via gut dysbiosis and increased intestinal permeability [110–112].”
BackgroundHELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230 · cited 2×
“[39] F.”
BackgroundZeissig, S., Bürgel, N., Günzel, D., Richter, J., Mankertz, J., Wahnschaffe, U., Kroesen, A. J., Zeitz, M., Fromm, M., & Schulzke, J.-D. (2007) · Gut · doi:10.1136/gut.2006.094375 · Cited by 1,223 · cited 1×
“Furthermore, an ex vivo study using Ussing chambers on colonic biopsies from CD patients [31] demonstrated a spatially uniform increase in transepithelial conductivity despite the presence of minimal mucosal erosions.”
Backgroundthe Wellcome Trust Case Control Consortium, Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. R., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,155
Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases
Lee, S. H. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.1.11 · Cited by 807 · cited 1×
“IBD patients display increased paracellular permeability [28] with TJs abnormalities documented in several studies [29, 30].”
BackgroundHOLLANDER, D., VADHEIM, C. M., BRETTHOLZ, E., PETERSEN, G. M., DELAHUNTY, T., & ROTTER, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 760 · cited 2×
“On the other hand, genes involved in intestinal barrier homeostasis have been associated with IBD susceptibility [56] suggesting a genetic predisposition that is further supported by the observation that up to 40% of first-degree relatives of CDpatients display an altered small intestinal permeability [57–62], with si…”
BackgroundDeletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease
McCarroll, S. A., Huett, A., Kuballa, P., Chilewski, S. D., Landry, A., Goyette, P., Zody, M. C., Hall, J. L., Brant, S. R., Cho, J. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.215 · Cited by 655 · cited 2×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundIntestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626
Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
Serino, M., Luche, E., Gres, S., Baylac, A., Bergé, M., Cenac, C., Waget, A., Klopp, P., Iacovoni, J., Klopp, C., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301012 · Cited by 615 · cited 2×
“Western diet with its high content of fat and refined sugars is a risk factor for the development of CD [109] probably inducing a low-grade inflammation via gut dysbiosis and increased intestinal permeability [110–112].”
BackgroundImportance of disrupted intestinal barrier in inflammatory bowel diseases
Salim, S. Y., & Söderholm, J. D. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21403 · Cited by 602 · cited 1×
“IBD patients display increased paracellular permeability [28] with TJs abnormalities documented in several studies [29, 30].”
BackgroundRole of the Gut in Multiple Organ Failure: Bacterial Translocation and Permeability Changes
Swank, G. M., & Deitch, E. A. (1996) · World Journal of Surgery · doi:10.1007/s002689900065 · Cited by 566 · cited 1×
“Altered intestinal permeability has been documented during several conditions, namely, acute pancreatitis [12], multiple organ failure [13], major surgery [14, 15], and severe trauma [16], and could explain the high prevalence of Gramnegative sepsis and related mortality in critically ill patients [8].”
BackgroundNod2 is required for the regulation of commensal microbiota in the intestine
Petnicki-Ocwieja, T., Hrncir, T., Liu, Y.-J., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H., & Kobayashi, K. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907722106 · Cited by 564 · cited 1×
“In intestinal mucosa, the lack of feedback between mutated NOD2/CARD15 expression and gut luminal microbiota can lead to the breakdown of tolerance [73].”
BackgroundMartinez-Medina, M., Denizot, J., Dreux, N., Robin, F., Billard, E., Bonnet, R., Darfeuille-Michaud, A., & Barnich, N. (2014) · Gut · doi:10.1136/gutjnl-2012-304119 · Cited by 539 · cited 2×
“Western diet with its high content of fat and refined sugars is a risk factor for the development of CD [109] probably inducing a low-grade inflammation via gut dysbiosis and increased intestinal permeability [110–112].”
BackgroundGut microbiota and metabolic syndrome
Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16079 · Cited by 534 · cited 1×
“Indeed the altered microbiota has been linked not only to gastrointestinal diseases but also to the pathogenesis of systemic conditions such as obesity and metabolic syndrome [6, 7].”
BackgroundPeng, L., He, Z., Chen, W., Holzman, I. R., & Lin, J. (2007) · Pediatric Research · doi:10.1203/01.pdr.0000250014.92242.f3 · Cited by 518 · cited 1×
“[119] L.”
Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01500-13 · Cited by 509 · cited 1×
“To date the ones with proven efficacy are Escherichia coli Nissle 1917, Bifidobacterium, Lactobacillus rhamnosus GG, or the multispecies VSL#3 which contains eight different probiotics [132].”
BackgroundProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482 · cited 1×
“Themechanisms of their effect in UC have not been fully understood but probably, along with direct anti-inflammatory effects, they may strengthen mucosal barrier [134, 135] and reduce intestinal permeability once again upregulating TJs proteins [136, 137].”
BackgroundLerner, A., & Matthias, T. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.01.009 · Cited by 475 · cited 2×
“A recent review showed the ability of additives to increase intestinal permeability by interfering with the TJs, promoting the passage of immunogenic antigens [113].”
BackgroundThickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.
Pullan, R. D., Thomas, G. A., Rhodes, M., Newcombe, R. G., Williams, G. T., Allen, A., & Rhodes, J. (1994) · Gut · doi:10.1136/gut.35.3.353 · Cited by 467 · cited 1×
“Ulcerative Colitis (UC) patients show a reduced number of goblet cells [42], a reduced thickness of the mucus layer [43, 44], and an altered mucus composition in terms ofmucins, phosphatidylcholine, and glycosylation [45–48].”
BackgroundWilling, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455 · cited 1×
“This may represent a consequence of chronic mucosal inflammation but the influence of host genotype in shaping microbial community cannot be overlooked inCD [75] andNOD2/CARD15 genotype has been shown to influence the composition of gut microbiota in humans [76].”
BackgroundPastorelli, L., De Salvo, C., Mercado, J. R., Vecchi, M., & Pizarro, T. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00280 · Cited by 440 · cited 1×
“Butyrate is a short chain fatty acid produced by intestinal microbial fermentation of dietary fibres [115] which in experimental models stimulates mucus production and expression of TJs in vitro but a wider range of action is expected [116– 120].”
BackgroundMicrobial butyrate and its role for barrier function in the gastrointestinal tract
Plöger, S., Stumpff, F., Penner, G. B., Schulzke, J., Gäbel, G., Martens, H., Shen, Z., Günzel, D., & Aschenbach, J. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06553.x · Cited by 435
Intestinal barrier in inflammatory bowel disease
Antoni, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1165 · Cited by 413 · cited 5×
“Indeed, the diminished Paneth cell antimicrobial function might be a primary pathogenic factor in CD, particularly ileal CD [24, 43, 52, 53], while the increased secretion of defensins in UC may be a physiological response to mucosal damage.”
BackgroundInfluentialAnti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
Suenaert, P. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04271-5 · Cited by 399 · cited 2×
“Agents routinely used in the therapeutic armamentarium of IBD may induce and maintain mucosal remission not only for their immunomodulating effect, but also through the restoration of epithelial integrity and permeability, as has been demonstrated for anti-TNF-α drugs in CD [37, 106].”
BackgroundSu, L., Nalle, S. C., Shen, L., Turner, E. S., Singh, G., Breskin, L. A., Khramtsova, E. A., Khramtsova, G., Tsai, P., Fu, Y., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.011 · Cited by 397
Camilleri, M., Lasch, K., & Zhou, W. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00155.2012 · Cited by 396 · cited 2×
“Furthermore, perturbation of the complex mechanism of permeability has been associated with the development of irritable bowel syndrome [17–19] and steatohepatitis (NASH) [20, 21].”
BackgroundKiesslich, R., Duckworth, C. A., Moussata, D., Gloeckner, A., Lim, L. G., Goetz, M., Pritchard, D. M., Galle, P. R., Neurath, M. F., & Watson, A. J. M. (2012) · Gut · doi:10.1136/gutjnl-2011-300695 · Cited by 391 · cited 1×
“Far from being just speculative findings these alterationsmay represent a subclinical impairment of intestinal permeability possibly predicting subsequent clinical relapse [104].”
Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon
Barcelo, A., Claustre, J., Moro, F., Chayvialle, J.-A., Cuber, J.-C., & Plaisancié, P. (2000) · Gut · doi:10.1136/gut.46.2.218 · Cited by 375
Schmitz, H., Fromm, M., Bentzel, C. J., Scholz, P., Detjen, K., Mankertz, J., Bode, H., Epple, H.-J., Riecken, E.-O., & Schulzke, J.-D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.1.137 · Cited by 375
Buhner, S., Buning, C., Genschel, J., Kling, K., Herrmann, D., Dignass, A., Kuechler, I., Krueger, S., Schmidt, H. H.-J., & Lochs, H. (2006) · Gut · doi:10.1136/gut.2005.065557 · Cited by 368 · cited 1×
“On the other hand, genes involved in intestinal barrier homeostasis have been associated with IBD susceptibility [56] suggesting a genetic predisposition that is further supported by the observation that up to 40% of first-degree relatives of CDpatients display an altered small intestinal permeability [57–62], with si…”
BackgroundLarsson, J. M. H., Karlsson, H., Crespo, J. G., Johansson, M. E. V., Eklund, L., Sjövall, H., & Hansson, G. C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21625 · Cited by 360
Vivinus-Nébot, M., Frin-Mathy, G., Bzioueche, H., Dainese, R., Bernard, G., Anty, R., Filippi, J., Saint-Paul, M. C., Tulic, M. K., Verhasselt, V, et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304066 · Cited by 348 · cited 2×
“This gene, which is involved in bacterial recognition, modulates both innate and adaptive immune responses and is themain susceptibility locus for CD development [55].”
BackgroundIntestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis
Wu, S., Zhang, Y.-G., Lu, R., Xia, Y., Zhou, D., Petrof, E. O., Claud, E. C., Chen, D., Chang, E. B., Carmeliet, G., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307436 · Cited by 345
Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function
Patel, R. M., Myers, L. S., Kurundkar, A. R., Maheshwari, A., Nusrat, A., & Lin, P. W. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.025 · Cited by 341
Fritscher-Ravens, A., Schuppan, D., Ellrichmann, M., Schoch, S., Röcken, C., Brasch, J., Bethge, J., Böttner, M., Klose, J., & Milla, P. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.046 · Cited by 329 · cited 1×
“Confocal laser endomicroscopy is now widely used in diagnosis and classification of gastrointestinal tumours [94– 97] but it has also been applied in nonneoplastic conditions such as celiac disease [98], collagenous colitis [99], and irritable bowel syndrome [100].”
MethodPASSCLAIM1?Gut health and immunity
Cummings, J. H., Antoine, J.-M., Azpiroz, F., Bourdet-Sicard, R., Brandtzaeg, P., Calder, P. C., Gibson, G. R., Guarner, F., Isolauri, E., Pannemans, D., et al. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-1205-4 · Cited by 324 · cited 2×
“Altered intestinal permeability has been documented during several conditions, namely, acute pancreatitis [12], multiple organ failure [13], major surgery [14, 15], and severe trauma [16], and could explain the high prevalence of Gramnegative sepsis and related mortality in critically ill patients [8].”
BackgroundNod2 is essential for temporal development of intestinal microbial communities
Rehman, A., Sina, C., Gavrilova, O., Häsler, R., Ott, S., Baines, J. F., Schreiber, S., & Rosenstiel, P. (2011) · Gut · doi:10.1136/gut.2010.216259 · Cited by 316 · cited 1×
“This may represent a consequence of chronic mucosal inflammation but the influence of host genotype in shaping microbial community cannot be overlooked inCD [75] andNOD2/CARD15 genotype has been shown to influence the composition of gut microbiota in humans [76].”
BackgroundIs small intestinal permeability really increased in relatives of patients with Crohn's disease?
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90638-s · Cited by 314
The tight junction in inflammatory disease: communication breakdown
Edelblum, K. L., & Turner, J. R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.022 · Cited by 314 · cited 2×
“[33] K.”
BackgroundAltered permeability in inflammatory bowel disease: pathophysiology and clinical implications
Mankertz, J., & Schulzke, J.-D. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32816aa392 · Cited by 312 · cited 1×
“Increasing evidence suggests that intestinal permeability may be crucial [23, 24] and some authors even considered IBD as an impaired barrier disease [25].”
BackgroundTight junction, selective permeability, and related diseases
Krug, S. M., Schulzke, J. D., & Fromm, M. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.09.002 · Cited by 306 · cited 2×
“[34] S.”
BackgroundIntestinal microbiota in inflammatory bowel disease: Friend of foe?
Fava, F. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.557 · Cited by 300 · cited 1×
“This dysbiosis may further aggravate permeability dysfunction by the loss of the symbiotic relationship between the microbiota and the mucosal barrier integrity [77].”
BackgroundWehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., Schroeder, J. M., & Stange, E. F. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00001 · Cited by 295 · cited 1×
“However, the role of Paneth cells may be different in the two disease phenotypes since the expression of defensins is inducible by colonic inflammation in UC but is reduced in patients with colonic Crohn’s disease (CD) [51].”
BackgroundIrvine, E. J., & Marshall, J. K. (2000) · Gastroenterology · doi:10.1053/gast.2000.20231 · Cited by 286 · cited 1×
“Finally, to date there is only one reported case of CD development predicted by an abnormal permeability test in a healthy relative [66].”
BackgroundMartínez, C., Lobo, B., Pigrau, M., Ramos, L., González-Castro, A. M., Alonso, C., Guilarte, M., Guilá, M., de Torres, I., Azpiroz, F., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302093 · Cited by 283
Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
Borody, T. J., Paramsothy, S., & Agrawal, G. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0337-1 · Cited by 275 · cited 1×
“The gastrointestinal microbiota, whose genome contains one hundredfold more genes than the entire human genome [3, 4], has important roles in nutrition, energy metabolism, host defense, and immune system development [5].”
BackgroundAbsorption of 151chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease
Bjarnason, I., O'Morain, C., Levi, A. J., & Peters, T. J. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90317-7 · Cited by 266
Clustering of increased small intestinal permeability in families with Crohn's disease
Peeters, M., Geypens, B., Claus, D., Nevens, H., Ghoos, Y., Verbeke, G., Baert, F., Vermeire, S., Vlietinck, R., & Rutgeerts, P. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70174-4 · Cited by 261 · cited 1×
“Other studies have not found a correlation between permeability and genetic polymorphisms [60, 62, 65] but it is noteworthy that they have mostly involved sporadic CD cases.”
BackgroundVitamin D receptor gene polymorphism: association with Crohn's disease susceptibility
Simmons, J. D., Mullighan, C., Welsh, K. I., & Jewell, D. P. (2000) · Gut · doi:10.1136/gut.47.2.211 · Cited by 261 · cited 1×
“Finally, vitamin D is worth a mention because it is involved in maintaining intestinal barrier function [113] and polymorphisms of its receptor have been associated with the development of IBD [142, 143].”
BackgroundVetrano, S., Rescigno, M., Rosaria Cera, M., Correale, C., Rumio, C., Doni, A., Fantini, M., Sturm, A., Borroni, E., Repici, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.002 · Cited by 254 · cited 2×
“[32] S.”
BackgroundNighot, P. K., Hu, C.-A. A., & Ma, T. Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597492 · Cited by 242
Jonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundRole of diet in the development of inflammatory bowel disease
Chapman-Kiddell, C. A., Davies, P. S. W., Gillen, L., & Radford-Smith, G. L. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20968 · Cited by 235 · cited 1×
“Western diet with its high content of fat and refined sugars is a risk factor for the development of CD [109] probably inducing a low-grade inflammation via gut dysbiosis and increased intestinal permeability [110–112].”
BackgroundColonic mucin synthesis is increased by sodium butyrate.
Finnie, I. A., Dwarakanath, A. D., Taylor, B. A., & Rhodes, J. M. (1995) · Gut · doi:10.1136/gut.36.1.93 · Cited by 231
Munkholm, P., Langholz, E., Hollander, D., Thornberg, K., Orholm, M., Katz, K. D., & Binder, V (1994) · Gut · doi:10.1136/gut.35.1.68 · Cited by 225 · cited 2×
“On the other hand, genes involved in intestinal barrier homeostasis have been associated with IBD susceptibility [56] suggesting a genetic predisposition that is further supported by the observation that up to 40% of first-degree relatives of CDpatients display an altered small intestinal permeability [57–62], with si…”
BackgroundCunliffe, R. N. (2001) · Gut · doi:10.1136/gut.48.2.176 · Cited by 221 · cited 1×
“Moreover, altered Paneth cell distribution and function have been documented in IBD: these cells are normally restricted to the small intestines, within the crypts of Lieberkühn, but in IBD metaplastic Paneth cells may be detected in colonic mucosa, with subsequent secretion of defensins also in the large intestine [2…”
BackgroundIntestinal permeability test as a predictor of clinical course in Crohn's disease
D'Incà, R. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00500-6 · Cited by 219
Self-citationIdentification of Epithelial Gaps in Human Small and Large Intestine by Confocal Endomicroscopy
Kiesslich, R., Goetz, M., Angus, E. M., Hu, Q., Guan, Y., Potten, C., Allen, T., Neurath, M. F., Shroyer, N. F., Montrose, M. H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.011 · Cited by 217 · cited 1×
“The up to one thousandfold magnification permits detection of cellular and subcellular changes such as cell shedding [101], making it a powerful technique for the imaging of any defects inmucosal barrier in IBD.”
BackgroundVernia, P., Annese, V., Bresci, G., D’Albasio, G., D’Incà, R., Giaccari, S., Ingrosso, M., Mansi, C., Riegler, G., Valpiani, D., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01130.x · Cited by 217 · cited 1×
“In clinical practice topical butyrate had proved efficacy in refractory distal UC [123].”
BackgroundSelf-citationLorenz-Meyer, H., Bauer, P., Nicolay, C., Schulz, B., Purrmann, J., Fleig, W. E., Scheurlen, C., Koop, I., Pudel, V., & Carr, L. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609010352 · Cited by 211 · cited 2×
“Other fatty acids with similar properties have also been proposed as an adjuvant therapy in IBD, namely, omega-3 and phosphatidylcholine [124–126], but their use in clinical practice is still limited.”
BackgroundMüller, C. A., Autenrieth, I. B., & Peschel, A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5034-2 · Cited by 207 · cited 1×
“Moreover, altered Paneth cell distribution and function have been documented in IBD: these cells are normally restricted to the small intestines, within the crypts of Lieberkühn, but in IBD metaplastic Paneth cells may be detected in colonic mucosa, with subsequent secretion of defensins also in the large intestine [2…”
BackgroundKunisawa, J., & Kiyono, H. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5035-1 · Cited by 203
Braun, A., Treede, I., Gotthardt, D., Tietje, A., Zahn, A., Ruhwald, R., Schoenfeld, U., Welsch, T., Kienle, P., Erben, G., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20993 · Cited by 201 · cited 2×
“[45] A.”
BackgroundEpithelial permeability to proteins in the noninflamed ileum of Crohn's disease?
Söderholm, J. D., Peterson, K. H., Olaison, G., Franzén, L. E., Weström, B., Magnusson, K.-E., & Sjödahl, R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70551-2 · Cited by 201 · cited 1×
“IBD patients display increased paracellular permeability [28] with TJs abnormalities documented in several studies [29, 30].”
BackgroundZakostelska, Z., Kverka, M., Klimesova, K., Rossmann, P., Mrazek, J., Kopecny, J., Hornova, M., Srutkova, D., Hudcovic, T., Ridl, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027961 · Cited by 199 · cited 1×
“Themechanisms of their effect in UC have not been fully understood but probably, along with direct anti-inflammatory effects, they may strengthen mucosal barrier [134, 135] and reduce intestinal permeability once again upregulating TJs proteins [136, 137].”
BackgroundMarini, M., Bamias, G., Rivera-Nieves, J., Moskaluk, C. A., Hoang, S. B., Ross, W. G., Pizarro, T. T., & Cominelli, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432897100 · Cited by 197 · cited 2×
“[38] M.”
BackgroundIntestinal Epithelium in Inflammatory Bowel Disease
Coskun, M. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00024 · Cited by 197 · cited 2×
“The pathogenesis of inflammatory bowel disease (IBD) is still unclear but in all probability is multifactorial and driven by an exaggerated immune response towards gutmicrobiome in a genetically susceptible host [22].”
BackgroundIntestinal epithelial cells in inflammatory bowel diseases
Roda, G., Sartini, A., Zambon, E., Calafiore, A., Marocchi, M., Caponi, A., Belluzzi, A., & Roda, E. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i34.4264 · Cited by 195 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundZinc Supplementation Tightens “Leaky Gut” in Crohn’s Disease
Sturniolo, G. C., Di Leo, V., Ferronato, A., D’Odorico, A., & D’Incà, R. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00003 · Cited by 192
Self-citationUkabam, S. O., Clamp, J. R., & Cooper, B. T. (1983) · Digestion · doi:10.1159/000198932 · Cited by 189
Canto, M. I., Anandasabapathy, S., Brugge, W., Falk, G. W., Dunbar, K. B., Zhang, Z., Woods, K., Almario, J. A., Schell, U., Goldblum, J., et al. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.09.020 · Cited by 187
Garcia Vilela, E., De Lourdes De Abreu Ferrari, M., Oswaldo Da Gama Torres, H., Guerra Pinto, A., Carolina Carneiro Aguirre, A., Paiva Martins, F., Marcos Andrade Goulart, E., & Sales Da Cunha, A. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520801943354 · Cited by 184 · cited 1×
“Themechanisms of their effect in UC have not been fully understood but probably, along with direct anti-inflammatory effects, they may strengthen mucosal barrier [134, 135] and reduce intestinal permeability once again upregulating TJs proteins [136, 137].”
BackgroundEffect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model
Mariadason, J. M., Barkla, D. H., & Gibson, P. R. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.4.g705 · Cited by 182 · cited 1×
“[118] J.”
Sucrose: A novel permeability marker for gastroduodenal disease
Meddings, J. B., Sutherland, L. R., Byles, N. I., & Wallace, J. L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90637-r · Cited by 178 · cited 1×
“Other sugars are routinely used to evaluate the upper intestinal tract, such as sucrose which is degraded by duodenal sucrase, thus reflecting the permeability of the stomach and the proximal duodenum [9, 88].”
BackgroundIntestinal microbiota, probiotics and prebiotics in inflammatory bowel disease
Orel, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11505 · Cited by 177 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundRetarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
Stremmel, W. (2005) · Gut · doi:10.1136/gut.2004.052316 · Cited by 176 · cited 2×
“Other fatty acids with similar properties have also been proposed as an adjuvant therapy in IBD, namely, omega-3 and phosphatidylcholine [124–126], but their use in clinical practice is still limited.”
BackgroundRoy, S. K., Behrens, R. H., Haider, R., Akramuzzaman, S. M., Mahalanabis, D., Wahed, M. A., & Tomkins, A. M. (1992) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1992.tb10656.x · Cited by 174 · cited 2×
“[127] S.”
BackgroundTanaka, H., Takechi, M., Kiyonari, H., Shioi, G., Tamura, A., & Tsukita, S. (2015) · Gut · doi:10.1136/gutjnl-2014-308419 · Cited by 173 · cited 1×
“A decreased expression and redistribution of their constituents, including occludins, claudins, and junctional adhesion molecules (JAM), have all been documented in IBD [31–34] and a recent experimental mouse model found that deletion of claudin-7 initiates colonic inflammation [35].”
BackgroundSanderson, I. R., Boulton, P., Menzies, I., & Walker-Smith, J. A. (1987) · Gut · doi:10.1136/gut.28.9.1073 · Cited by 170 · cited 1×
“Since similar effects have been obtained using elemental diets in CD [107, 108], increasing interest relies on dietary approacheswith the use of immunomodulatory nutrients and probiotics.”
BackgroundThe microbiome and obesity: Is obesity linked to our gut flora?
Tsai, F., & Coyle, W. J. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0045-z · Cited by 165 · cited 1×
“The gastrointestinal microbiota, whose genome contains one hundredfold more genes than the entire human genome [3, 4], has important roles in nutrition, energy metabolism, host defense, and immune system development [5].”
BackgroundInnate immune dysfunction in inflammatory bowel disease
Gersemann, M., Wehkamp, J., & Stange, E. F. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02515.x · Cited by 165 · cited 2×
“Indeed, the diminished Paneth cell antimicrobial function might be a primary pathogenic factor in CD, particularly ileal CD [24, 43, 52, 53], while the increased secretion of defensins in UC may be a physiological response to mucosal damage.”
BackgroundThe effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
Teahon, K., Smethurst, P., Pearson, M., Levi, A. J., & Bjarnason, I. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90463-u · Cited by 163 · cited 1×
“Since similar effects have been obtained using elemental diets in CD [107, 108], increasing interest relies on dietary approacheswith the use of immunomodulatory nutrients and probiotics.”
BackgroundInflammatory bowel disease: an impaired barrier disease
Jäger, S., Stange, E. F., & Wehkamp, J. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-1030-9 · Cited by 158 · cited 2×
“Increasing evidence suggests that intestinal permeability may be crucial [23, 24] and some authors even considered IBD as an impaired barrier disease [25].”
BackgroundRussell, R. K., & Satsangi, J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.12.006 · Cited by 140 · cited 1×
“However, environmental factors too are main contributors in determining mucosal permeability since permeability is increased even in a proportion of CD spouses [61].”
BackgroundThe role of immunomodulators on intestinal barrier homeostasis in experimental models
Andrade, M. E. R., Araújo, R. S., de Barros, P. A. V., Soares, A. D. N., Abrantes, F. A., Generoso, S. D. V., Fernandes, S. O. A., & Cardoso, V. N. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.01.012 · Cited by 138 · cited 1×
“On the contrary, certain fatty acids (propionate, acetate, butyrate, omega-3, and conjugated linoleic acid), amino acids (glutamine, arginine, tryptophan, and citrulline), and oligoelements, essential for intestinal surface integrity, when supplemented to experimental models of gut diseases, can reduce inflammation an…”
Backgroundvan Wijck, K., Verlinden, T. J. M., van Eijk, H. M. H., Dekker, J. P., Buurman, W. A., Dejong, C. H. C., & Lenaerts, K. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.014 · Cited by 137
Li, Y. C., Chen, Y., & Du, J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.01.011 · Cited by 136 · cited 1×
“While the expression of vitamin D receptor on intestinal epithelium inhibits inflammation-induced apoptosis [144], its deletion leads to defective autophagy that promotes experimental colitis [145].”
BackgroundBacterial-mucosal interactions in inflammatory bowel disease—an alliance gone bad
Chichlowski, M., & Hale, L. P. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90516.2008 · Cited by 134 · cited 1×
“Independently from being genetically determined or caused by environmental factors, permeability impairment leads to the disruption of the physiological balance between mucosal barrier and luminal challenge [25] which cannot be adequately counteracted by innate immunity of IBD patients, which on the contrary responds…”
BackgroundRole of Corticotropin-releasing Factor in Gastrointestinal Permeability
Rodiño‐Janeiro, B. K., Alonso, C., Pigrau, M., Lobo, B., Vicario, M., & Santos, J. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14084 · Cited by 129 · cited 1×
“Indeed, some of the known risk factors for disease relapse may induce inflammation through the increased mucosal permeability: this is a well-known mechanism for nonsteroids anti-inflammatory drugs (NSAIDs) [78] and recent evidence demonstrated that even stress acts in a similar manner through the release of corticotr…”
BackgroundTNF‐α–induced intestinal epithelial cell shedding: implications for intestinal barrier function
Watson, A. J. M., & Hughes, K. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06523.x · Cited by 128
Effect of zinc supplementation on intestinal permeability in experimental colitis
Sturniolo, G. C., Fries, W., Mazzon, E., Leo, V. D., Barollo, M., & Renata D'Incà (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.123624 · Cited by 127 · cited 1×
“CD patients probably through its ability tomodulate TJs both in the small and the large bowels [130, 131].”
BackgroundSelf-citationRaouf, A. H., Tsai, H. H., Parker, N., Hoffman, J., Walker, R. J., & Rhodes, J. M. (1992) · Clinical Science · doi:10.1042/cs0830623 · Cited by 125
Abnormal intestinal permeability in Crohn's disease pathogenesis
Teshima, C., Dieleman, L. A., & Meddings, J. B. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06612.x · Cited by 122
Mujagic, Z., Ludidi, S., Keszthelyi, D., Hesselink, M., Kruimel, J. W., Lenaerts, K., Hanssen, N. M. J., Conchillo, J. M., Jonkers, D. M. A. E., & Masclee, A. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12829 · Cited by 112 · cited 2×
“Furthermore, perturbation of the complex mechanism of permeability has been associated with the development of irritable bowel syndrome [17–19] and steatohepatitis (NASH) [20, 21].”
BackgroundBecker, V., von Delius, S., Bajbouj, M., Karagianni, A., Schmid, R. M., & Meining, A. G. (2008) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.01.033 · Cited by 110 · cited 1×
“this endoscopic technique allows an in vivo evaluation of the epithelial lining and vasculature with the use of intravenous fluorescein as a molecular contrast agent, which usually does not have paracellular transport [93].”
Alam, A. N., Sarker, S., Wahed, M. A., Khatun, M., & Rahaman, M. (1994) · Gut · doi:10.1136/gut.35.12.1707 · Cited by 105 · cited 2×
“[128] A.”
BackgroundShahid, M. W., Buchner, A. M., Heckman, M. G., Krishna, M., Raimondo, M., Woodward, T. A., & Wallace, M. B. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.376 · Cited by 100
Phosphatidylcholine for Steroid-Refractory Chronic Ulcerative Colitis
Stremmel, W., Ehehalt, R., Autschbach, F., & Karner, M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-9-200711060-00004 · Cited by 96
Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease
Renata D'Incà, Annese, V., Leo, V. D., Latiano, A., Quaino, V., Abazia, C., Vettorato, M. G., & Sturniolo, G. C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02916.x · Cited by 95
Self-citationRt, J., Ramage, J. K., Jones, D. B., Collins, S. M., Goodacre, R. L., & Hunt, R. H. (1988) · PubMed · Cited by 93
Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study
Buda, A., Hatem, G., Neumann, H., Renata D'Incà, Mescoli, C., Piselli, P., Jackson, J., Bruno, M. J., & Sturniolo, G. C. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.09.005 · Cited by 91 · cited 5×
“Buda and with permission of Journal of Crohn’s and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.”
BackgroundMethodInfluentialSelf-citationLiu, J. J., Madsen, K. L., Boulanger, P., Dieleman, L. A., Meddings, J. B., & Fedorak, R. N. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181fbdb8a · Cited by 89 · cited 1×
“Confocal laser endomicroscopy demonstrated increased density of mucosal gaps after cell shedding in small bowel of CD patients [102] but also in macroscopically normal duodenum in both CD and UC [103].”
BackgroundNew Insight in Loss of Gut Barrier during Major Non-Abdominal Surgery
Derikx, J. P. M., van Waardenburg, D. A., Thuijls, G., Willigers, H. M., Koenraads, M., van Bijnen, A. A. J. H. M., Heineman, E., Poeze, M., Ambergen, T., van Ooij, A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003954 · Cited by 86 · cited 1×
“Altered intestinal permeability has been documented during several conditions, namely, acute pancreatitis [12], multiple organ failure [13], major surgery [14, 15], and severe trauma [16], and could explain the high prevalence of Gramnegative sepsis and related mortality in critically ill patients [8].”
Backgroundde Haan, J. J., Lubbers, T., Derikx, J. P. M., Relja, B., Henrich, D. M., Greve, J.-W. M., Marzi, İ., & Buurman, W. A. (2009) · Critical Care · doi:10.1186/cc7910 · Cited by 84
Persborn, M., Gerritsen, J., Wallon, C., Carlsson, A. H., Akkermans, L. M. A., & Söderholm, J. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12451 · Cited by 83 · cited 1×
“Even the beneficial effect of probiotics in pouchitis seems to be related to the enhancement ofmucosal barrier function [138].”
BackgroundA. Venkatraman, B. S. R. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200451171 · Cited by 83 · cited 1×
“It is so crucial for general homeostasis of enterocytes that its deficiency, measured as faecal concentrations, has been taken as an indirect indicator of altered barrier function [9, 121, 122].”
BackgroundFries, W., Renda, M. C., Presti, M. A. L., RASO, A. F., Orlando, A., Oliva, L., Giofré, M. R., Maggio, A., Mattaliano, A. R., Macaluso, A., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00325.x · Cited by 82 · cited 2×
“Other studies have not found a correlation between permeability and genetic polymorphisms [60, 62, 65] but it is noteworthy that they have mostly involved sporadic CD cases.”
BackgroundLim, L. G., Neumann, J. P., Hansen, T., Goetz, M., Hoffman, A. W., Neurath, M. F., Galle, P. R., Chan, Y. H., Kießlich, R., & Watson, A. J. M. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000027 · Cited by 81 · cited 1×
“Confocal laser endomicroscopy demonstrated increased density of mucosal gaps after cell shedding in small bowel of CD patients [102] but also in macroscopically normal duodenum in both CD and UC [103].”
BackgroundStudy of the Carbohydrate Content of Mucus Glycoproteins from Normal and Diseased Colons
Clamp, J. R., Fraser, G., & Read, A. E. (1981) · Clinical Science · doi:10.1042/cs0610229 · Cited by 80
Martin, T. D., Chan, S. S. M., & Hart, A. R. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3437-3 · Cited by 78 · cited 1×
“Indeed, some of the known risk factors for disease relapse may induce inflammation through the increased mucosal permeability: this is a well-known mechanism for nonsteroids anti-inflammatory drugs (NSAIDs) [78] and recent evidence demonstrated that even stress acts in a similar manner through the release of corticotr…”
BackgroundFishman, J. E., Levy, G., Alli, V. V., Zheng, X., Mole, D. J., & Deitch, E. A. (2014) · Shock · doi:10.1097/shk.0000000000000209 · Cited by 76 · cited 1×
“Altered intestinal permeability has been documented during several conditions, namely, acute pancreatitis [12], multiple organ failure [13], major surgery [14, 15], and severe trauma [16], and could explain the high prevalence of Gramnegative sepsis and related mortality in critically ill patients [8].”
BackgroundDresner–Pollak, R., Ackerman, Z., Eliakim, R., Karban, A. A., Chowers, Y., & Fidder, H. H. (2004) · Genetic Testing · doi:10.1089/gte.2004.8.417 · Cited by 75 · cited 1×
“Finally, vitamin D is worth a mention because it is involved in maintaining intestinal barrier function [113] and polymorphisms of its receptor have been associated with the development of IBD [142, 143].”
BackgroundShahid, M. W., Buchner, A. M., Coron, E., Woodward, T. A., Raimondo, M., Dekker, E., Fockens, P., & Wallace, M. B. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.08.024 · Cited by 72 · cited 2×
“[97] M.”
MethodAssessment of the lactulose-mannitol test in Crohn's disease.
Andre, F., Andre, C., Emery, Y., Forichon, J., Descos, L., & Minaire, Y. (1988) · Gut · doi:10.1136/gut.29.4.511 · Cited by 67 · cited 2×
“[86] F.”
MethodKevans, D., Turpin, W., Madsen, K. L., Meddings, J. B., Shestopaloff, K., Xu, W. L., Moreno‐Hagelsieb, G., Griffiths, A. M., Silverberg, M. S., Paterson, A. D., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000323 · Cited by 66 · cited 2×
“Other studies have not found a correlation between permeability and genetic polymorphisms [60, 62, 65] but it is noteworthy that they have mostly involved sporadic CD cases.”
BackgroundIncreased gastric and intestinal permeability in patients with Crohn's disease.
Wyatt, J., Oberhuber, G., Pongratz, S., Püspök, A., Moser, G., Novacek, G., Lochs, H. H., & Vogelsang, H. (1997) · PubMed · Cited by 65
Bok, G. H., Jeon, S. R., Cho, J. Y., Cho, J., Lee, W. C., Jin, S. Y., Choi, I. H., Kim, H. G., Lee, T. H., & Park, E. J. (2013) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.01.018 · Cited by 64
Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier
Chen, S.-J., Liu, X., Liu, J.-P., Xi-yan, Y., & Lu, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9468 · Cited by 63 · cited 1×
“Ulcerative Colitis (UC) patients show a reduced number of goblet cells [42], a reduced thickness of the mucus layer [43, 44], and an altered mucus composition in terms ofmucins, phosphatidylcholine, and glycosylation [45–48].”
BackgroundInnate antimicrobial host defense in small intestinal Crohn's disease
Koslowski, M. J., Beisner, J., Stange, E. F., & Wehkamp, J. (2009) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.011 · Cited by 60 · cited 1×
“Indeed, the diminished Paneth cell antimicrobial function might be a primary pathogenic factor in CD, particularly ileal CD [24, 43, 52, 53], while the increased secretion of defensins in UC may be a physiological response to mucosal damage.”
BackgroundCrohn’s disease-Defect in innate defence
Gersemann, M., Wehkamp, J., Fellermann, K., & Stange, E. F. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5499 · Cited by 59 · cited 1×
“Indeed, the diminished Paneth cell antimicrobial function might be a primary pathogenic factor in CD, particularly ileal CD [24, 43, 52, 53], while the increased secretion of defensins in UC may be a physiological response to mucosal damage.”
BackgroundGut Microbiota, Probiotics and Inflammatory Bowel Disease
Stephani, J., Radulovic, K., & Niess, J. H. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0122-5 · Cited by 57 · cited 1×
“The gastrointestinal microbiota, whose genome contains one hundredfold more genes than the entire human genome [3, 4], has important roles in nutrition, energy metabolism, host defense, and immune system development [5].”
BackgroundPironi, L., Miglioli, M., Ruggeri, E., Levorato, M., Dallasta, M. A., Corbelli, C., Nibali, M. G., & Barbara, L. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01540405 · Cited by 51
Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?
OʼSullivan, M. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001621 · Cited by 44
Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
Escobedo, G., López‐Ortiz, E., & Torres-Castro, I. (2014) · PubMed · Cited by 42
Gut Barrier Dysfunction in Critically Ill Surgical Patients With Abdominal Compartment Syndrome
Al-Bahrani, A. Z., Darwish, A., Hamza, N., Benson, J., EDDLESTON, J. M., Snider, R. H., Nylen, E. S., Becker, K. L., Barclay, G. R., & Ammori, B. J. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181da8d51 · Cited by 42 · cited 1×
“Altered intestinal permeability has been documented during several conditions, namely, acute pancreatitis [12], multiple organ failure [13], major surgery [14, 15], and severe trauma [16], and could explain the high prevalence of Gramnegative sepsis and related mortality in critically ill patients [8].”
BackgroundIntestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis
Scarpellini, E., Lupo, M., Iegri, C., Gasbarrini, A., Santis, A. D., & Tack, J. F. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216104334 · Cited by 39 · cited 1×
“Furthermore, perturbation of the complex mechanism of permeability has been associated with the development of irritable bowel syndrome [17–19] and steatohepatitis (NASH) [20, 21].”
BackgroundLeaky guts: intestinal permeability and NASH
Ray, K. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.15 · Cited by 38 · cited 1×
“Furthermore, perturbation of the complex mechanism of permeability has been associated with the development of irritable bowel syndrome [17–19] and steatohepatitis (NASH) [20, 21].”
BackgroundCollagenous colitis: a case series with confocal laser microscopy and histology correlation
Zambelli, A., Villanacci, V., Buscarini, E., Bassotti, G., & Albarello, L. (2008) · Endoscopy · doi:10.1055/s-2008-1077376 · Cited by 36 · cited 1×
“Confocal laser endomicroscopy is now widely used in diagnosis and classification of gastrointestinal tumours [94– 97] but it has also been applied in nonneoplastic conditions such as celiac disease [98], collagenous colitis [99], and irritable bowel syndrome [100].”
MethodButyrate-producing bacteria as pharmabiotics for inflammatory bowel disease
Marteau, P. R. (2013) · Gut · doi:10.1136/gutjnl-2012-304240 · Cited by 36 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHyperresponsiveness of the Mucosal Barrier in Crohnʼs Disease Is Not Tumor Necrosis Factor-Dependent
Suenaert, P., Bulteel, V., Vermeire, S., Noman, M., Assche, G. V., & Rutgeerts, P. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000168371.87283.4b · Cited by 35 · cited 1×
“Agents routinely used in the therapeutic armamentarium of IBD may induce and maintain mucosal remission not only for their immunomodulating effect, but also through the restoration of epithelial integrity and permeability, as has been demonstrated for anti-TNF-α drugs in CD [37, 106].”
BackgroundLeo, V. D. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80068-2 · Cited by 35 · cited 2×
“[129] V.”
BackgroundMoeinian, M., Ghasemi-Niri, S. F., Mozaffari, S., Abdolghaffari, A. H., Baeeri, M., Navaea-Nigjeh, M., & Abdollahi, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i31.10876 · Cited by 28
Lactulose/Mannitol Test Has High Efficacy for Excluding Organic Causes of Chronic Diarrhea
Leo, V. D., Renata D'Incà, Diaz-Granado, N., Fries, W., Venturi, C., D’Odorico, A., Martines, D., & Sturniolo, G. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07697.x · Cited by 25
Self-citationCaccaro, R., Renata D'Incà, Martinato, M., Pont, E. D., Pathak, S., Frigo, A. C., & Sturniolo, G. C. (2014) · BioMetals · doi:10.1007/s10534-014-9745-4 · Cited by 10
Self-citationConfocal endomicroscopy in the evaluation of celiac disease
Leong, R. W. L. (2010) · Endoscopy · doi:10.1055/s-0030-1255541 · Cited by 4 · cited 1×
“Confocal laser endomicroscopy is now widely used in diagnosis and classification of gastrointestinal tumours [94– 97] but it has also been applied in nonneoplastic conditions such as celiac disease [98], collagenous colitis [99], and irritable bowel syndrome [100].”
Method
Research works printed but not linked: 3
- D′Incà R., 1993, Can permeability to sugars predict relapses in Crohn′s disease?, Gut, 34, S50
- 10.1016/s0002-9270(03)00703-2 · DOI
- 10.1097/00005176-199210000-00010 · doi:10.1097/00005176-199210000-00010 · Paper page
Cited by
The intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,287
“Most in vivo permeability studies report the prevalence of increased gut permeability to be 40–50%, with the highest values for patients with active disease [46].”
BackgroundLeaky gut: mechanisms, measurement and clinical implications in humans
Camilleri, M. (2019) · Gut · doi:10.1136/gutjnl-2019-318427 · Cited by 1,081
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 759
“Local intestinal inflammation underlies the development of a number of gastrointestinal diseases, such as inflammatory bowel disease [43], Crohn’s disease [44], and ulcerative colitis (extensively reviewed recently in [45]).”
BackgroundNegative Effects of a High-Fat Diet on Intestinal Permeability: A Review
Rohr, M. W., Narasimhulu, C. A., Rudeski-Rohr, T. A., & Parthasarathy, S. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz061 · Cited by 751
Intestinal Barrier in Human Health and Disease
Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 533
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.